Cara Therapeutics Stock News

While market advocates will wince at accusations that investing is nothing more than legalized gambling, for these stocks with massive upside potential, I for one will have to concede that only specul

Cara Therapeutics, Inc. (NASDAQ:CARA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Matt Murphy - Manager, IR Christopher Posner - CEO Ryan Maynard - CFO Dr. Joana Gon

Cara Therapeutics (CARA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.52 per share a year ago.

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15,

STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patient

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go

STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of pat

Cara Therapeutics (NASDAQ:CARA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 2 0 1 0 Las

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go

STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of pat

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Upgrades For Nordstrom Inc (NYSE:JWN), Argus Research upgraded the previous rating of Hold to Buy. In the fourth quarter, Nordstrom showed an EPS of $0.74, compared to $1.23 from the year-ago quarter.

ADial Pharmaceuticals stock soars after alcohol disorder treatment clinical trial news, Squarespace rises after estimate-beating results.

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 450 points on Tuesday. The Dow traded down 1.68% to 32,868.40 while the NASDAQ fell 1.31% to 11,523.25. The S&P 5

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the Euro